948 related articles for article (PubMed ID: 23992124)
1. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
2. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
Moreira Neto F; Lourenço DM; Noguti MA; Morelli VM; Gil IC; Beltrão AC; Figueiredo MS
Braz J Med Biol Res; 2006 Oct; 39(10):1291-5. PubMed ID: 16906320
[TBL] [Abstract][Full Text] [Related]
3. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
7. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilic Mutations Among Patients with Sickle Cell Disease.
Nefissi RB; Ouali F; Massaoud T; Gritli N
Clin Lab; 2017 Nov; 63(11):1815-1818. PubMed ID: 29226645
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
[TBL] [Abstract][Full Text] [Related]
12. The Prevalence of Factor V Leiden (G1691A) and Methylenetetrahydrofolate Reductase C677T Mutations in Sickle Cell Disease in Western India.
Kangne HK; Jijina FF; Italia YM; Jain DL; Nadkarni AH; Ghosh KK; Colah RB
Clin Appl Thromb Hemost; 2015 Mar; 21(2):186-9. PubMed ID: 23869056
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
[TBL] [Abstract][Full Text] [Related]
15. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
16. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R
Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413
[TBL] [Abstract][Full Text] [Related]
18. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
Eroglu A; Egin Y; Cam R; Akar N
Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
[TBL] [Abstract][Full Text] [Related]
20. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]